HomeCompareBNPQY vs MRK

BNPQY vs MRK: Dividend Comparison 2026

BNPQY yields 7.71% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BNPQY wins by $81522.90M in total portfolio value
10 years
BNPQY
BNPQY
● Live price
7.71%
Share price
$49.61
Annual div
$3.83
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$81522.96M
Annual income
$79,541,688,735.75
Full BNPQY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BNPQY vs MRK

📍 BNPQY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBNPQYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BNPQY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BNPQY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BNPQY
Annual income on $10K today (after 15% tax)
$655.55/yr
After 10yr DRIP, annual income (after tax)
$67,610,435,425.39/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, BNPQY beats the other by $67,610,427,096.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BNPQY + MRK for your $10,000?

BNPQY: 50%MRK: 50%
100% MRK50/50100% BNPQY
Portfolio after 10yr
$40761.51M
Annual income
$39,770,849,266.94/yr
Blended yield
97.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BNPQY
Analyst Ratings
3
Hold
Consensus: Hold
Price Target
$44.50
-10.3% upside vs current
Range: $44.50 — $44.50
Altman Z
-0.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BNPQY buys
0
MRK buys
0
No recent congressional trades found for BNPQY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBNPQYMRK
Forward yield7.71%2.76%
Annual dividend / share$3.83$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$81522.96M$56.8K
Annual income after 10y$79,541,688,735.75$9,798.13
Total dividends collected$81387.47M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$44.50$128.54

Year-by-year: BNPQY vs MRK ($10,000, DRIP)

YearBNPQY PortfolioBNPQY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,242$1,542.48$11,206$366.19+$1.0KBNPQY
2$16,629$3,529.68$12,650$502.35+$4.0KBNPQY
3$26,755$8,961.51$14,407$694.19+$12.3KBNPQY
4$55,577$26,949.94$16,585$967.82+$39.0KBNPQY
5$164,109$104,641.23$19,342$1,363.89+$144.8KBNPQY
6$753,138$577,541.38$22,913$1,947.19+$730.2KBNPQY
7$5,760,032$4,954,174.40$27,662$2,823.89+$5.73MBNPQY
8$76,985,170$70,821,935.48$34,159$4,173.35+$76.95MBNPQY
9$1,851,652,517$1,769,278,385.42$43,337$6,308.80+$1851.61MBNPQY
10$81,522,956,929$79,541,688,735.75$56,776$9,798.13+$81522.90MBNPQY

BNPQY vs MRK: Complete Analysis 2026

BNPQYStock

BNP Paribas SA provides a range of banking and financial services in Europe, North America, Asia Pacific, and internationally. The company offers corporate and institutional banking services, such as consulting, financing and transaction banking for corporate clients and institutional investors; capital markets investment and financing; securities clearing, and custody services. It also provides commercial, and personal banking and services, including financing and leasing services, financing of individuals, and digital banking services, as well as current and savings account products, equipment leasing and financing solutions, and consumer loans. In addition, the company offers investment and protection services, which includes borrowers' insurance, which protects the insured party from the unexpected when taking out a mortgage, personal, auto, or consumer loan; savings and protection solutions comprising life insurance, employee savings, retirement savings, etc.; asset management, wealth management, and real estate services. The company was formerly known as Banque Nationale de Paris and changed its name to BNP Paribas SA in May 2000. BNP Paribas SA was founded in 1822 and is headquartered in Paris, France.

Full BNPQY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BNPQY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BNPQY vs SCHDBNPQY vs JEPIBNPQY vs OBNPQY vs KOBNPQY vs MAINBNPQY vs JNJBNPQY vs ABBVBNPQY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.